To explore the prognostic predictive value of LOXL2 in glioma patients, Kaplan-Meier analysis and Cox proportional hazard model analysis were performed based on CGGA and TCGA database (Figures 6A, B). The gene discussed is LOXL2; the disease is central nervous system cancer.